PubRank

F Y Aoki

Author PubWeight™ 82.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009 13.51
2 Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997 6.23
3 Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000 5.03
4 Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986 4.37
5 Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988 2.82
6 Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet 1975 2.61
7 Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. JAMA 1996 1.89
8 Severe lithium intoxication: management without dialysis and report of a possible teratogenic effect of lithium. Can Med Assoc J 1971 1.54
9 Distribution and removal of human serum albumin-technetium 99m instilled intranasally. Br J Clin Pharmacol 1976 1.52
10 Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 2000 1.51
11 Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea. Clin Infect Dis 1997 1.51
12 Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer 2011 1.41
13 Intracerebroventricular and intraperitoneal disodium phosphonoacetate treatment of herpes simplex virus type I experimental encephalitis in rats. J Infect Dis 1979 1.27
14 Influenza immunization: knowledge, attitude and behaviour of health care workers. Can J Infect Control 1994 1.20
15 Oseltamivir: a clinical and pharmacological perspective. Expert Opin Pharmacother 2001 1.15
16 Treatment of wounds from animals suspected of carrying neurotropic viruses. Br Med J 1975 1.14
17 Immunization with a human diploid cell strain of rabies virus vaccine: two-year results. J Infect Dis 1978 1.09
18 Amantadine kinetics in healthy young subjects after long-term dosing. Clin Pharmacol Ther 1979 1.08
19 Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine. Antimicrob Agents Chemother 1985 1.04
20 Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small doses. Lancet 1976 1.04
21 Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections. Rev Infect Dis 1984 1.04
22 Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N Engl J Med 1997 1.04
23 Lithium intoxication. Can Med Assoc J 1972 1.02
24 An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipment. Burns 2001 1.00
25 Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group. J Infect Dis 1998 0.98
26 Amantadine kinetics in healthy elderly men: implications for influenza prevention. Clin Pharmacol Ther 1985 0.92
27 Randomized, double-blind, placebo-controlled, clinic-initiated, Canadian multicenter trial of topical edoxudine 3.0% cream in the treatment of recurrent genital herpes. Canadian Cooperative Study Group. J Infect Dis 1991 0.91
28 Naturally acquired serum rabies neutralizing antibody in a Canadian Inuit population. Arctic Med Res 1988 0.90
29 Clinical course of recurrent genital herpes and treatment with foscarnet cream: results of a Canadian multicenter trial. J Infect Dis 1987 0.90
30 Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine. Clin Pharmacol Ther 1993 0.90
31 Aging and heavy drug use: a prescription survey in Manitoba. J Chronic Dis 1983 0.90
32 Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization. J Hyg (Lond) 1982 0.90
33 Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection. Can J Clin Pharmacol 2001 0.84
34 Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS 2001 0.84
35 Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian forces personnel 1980-1983. Mil Med 1986 0.83
36 Prescribing patterns for older heavy drug users living in the community. DICP 1991 0.82
37 Prophylactic amantadine dose and plasma concentration-effect relationships in healthy adults. Clin Pharmacol Ther 1985 0.82
38 Human diploid-cell-culture vaccine for rabies prophylaxis. Can Med Assoc J 1979 0.82
39 Double-blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery 1983 0.81
40 Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis. Infection 1987 0.81
41 Frequency of changing enteral alimentation bags and tubing, and adverse clinical outcomes in patients in a long term care facility. Can J Infect Control 1993 0.81
42 A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma. Chest 1993 0.80
43 Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study. CMAJ 1988 0.80
44 Chronic tobacco smoking and gender as variables affecting amantadine disposition in healthy subjects. Br J Clin Pharmacol 1995 0.78
45 Amantadine acetylation may be effected by acetyltransferases other than NAT1 or NAT2. Can J Physiol Pharmacol 1999 0.78
46 Pseudomonas folliculitis in a resort whirlpool. Can Med Assoc J 1982 0.78
47 Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group. AIDS 2000 0.78
48 Respiratory failure in a man with bone and lung lesions. Hosp Pract (1995) 1998 0.77
49 Neonatal herpes simplex virus infection in Manitoba, 1980 to 1986, and implications for preventive strategies. Pediatr Infect Dis J 1988 0.77
50 Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine. J Allergy Clin Immunol 1987 0.77
51 Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trial. J Infect Dis 1997 0.76
52 Stress-induced reactivation of latent herpes simplex virus infection in rat lumbar dorsal root ganglia. J Psychosom Res 1993 0.76
53 Dermacase. Herpes simplex virus. Can Fam Physician 2001 0.75
54 Fatal diphtheria in an older woman. Can Med Assoc J 1985 0.75
55 Use of antiviral prophylaxis in influenza outbreaks in long term care facilities. Can J Infect Dis 2000 0.75
56 Double-blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Can Med Assoc J 1982 0.75
57 Enprofylline disposition in the presence and absence of amoxycillin or erythromycin. Br J Clin Pharmacol 1987 0.75
58 Partial characterization of alpha 1-acid glycoprotein isolated from mouse serum. Comp Biochem Physiol B 1987 0.75
59 Pharmacokinetic disposition of loracarbef in healthy young men and women at steady state. J Clin Pharmacol 1994 0.75
60 Effect of a polynucleotide interferon inducer of fungal origin on experimental rhinovirus infection in humans. J Infect Dis 1978 0.75
61 Pharmacokinetics and pharmacodynamics of bambuterol, a long-acting bronchodilator pro-drug of terbutaline, in young and elderly patients with asthma. Clin Pharmacol Ther 1992 0.75
62 Effect of acute experimental influenza A virus pneumonia on concentration of alpha 1-acid glycoprotein in mouse serum. Inflammation 1989 0.75
63 Amantadine prophylaxis during an institutional outbreak of type A influenza. Arch Intern Med 1987 0.75
64 Rabies vaccines. Nurs Times 1976 0.75
65 Slow release theophylline disposition and effect in elderly patients with chronic obstructive lung disease: influence of dose formulation and institutionalization. Biopharm Drug Dispos 1989 0.75
66 Nadolol antihypertensive effect and disposition in young and elderly adults with mild to moderate essential hypertension. Clin Pharmacol Ther 1989 0.75
67 Percutaneous feeding tube changes in long-term-care facility patients. Infect Control Hosp Epidemiol 1996 0.75
68 Characterization of acute and latent herpes simplex virus infection of dorsal root ganglia in rats. Lab Anim 1991 0.75
69 Immunohistological characterisation of acute herpes simplex virus infection of lumbar dorsal root ganglia in the rat. J Med Microbiol 1993 0.75
70 In vitro reactivation of latent herpes simplex virus by the demethylating compound hexamethylene-bis-acetamide. J Virol Methods 1992 0.75
71 Long-term captopril in young and old patients with mild hypertension. J Clin Pharmacol 1991 0.75